PM
PRCT icon

Prosight Management’s Procept Biorobotics PRCT Stock Holding History

Prosight Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.06M Sell
268,269
-1,676,731
-86% -$42M 1.04% 21
2026
Q1 		$48.6M Buy
1,945,000
+565,000
+41% +$15.9M 7.98% 4
2025
Q4 		$43.4M Buy
1,380,000
+1,303,009
+1,692% +$43.2M 8.97% 1
2025
Q3 		$2.75M Buy
+76,991
New +$3.52M 0.64% 29
2022
Q1 		– Sell
-20,000
Closed -$500K – 35
2021
Q4 		$500K Buy
+20,000
New +$740K 0.3% 33

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Prosight Management's PRCT Position: Q2 2026 in Review

Prosight Management reduced its Procept Biorobotics (PRCT) stake by 86% in Q2 2026, selling an estimated $42M and leaving 268,269 shares worth $6.06M. The position accounts for 1.04% of the portfolio, ranked #21.

Prosight Management first reported a position in PRCT in Q4 2021 and has held it in 5 quarters since. The position peaked at $48.6M in Q1 2026. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Prosight Management held 268,269 shares of Procept Biorobotics worth $6.06M as of Q2 2026.
  • Prosight Management sold 1,676,731 Procept Biorobotics shares in Q2 2026, an estimated $42M.
  • Procept Biorobotics made up 1.04% of Prosight Management's portfolio in Q2 2026, its #21 holding.
  • Prosight Management first reported a position in Procept Biorobotics in Q4 2021 and has held it in 5 quarters since.
  • Prosight Management's Procept Biorobotics position peaked at $48.6M in Q1 2026.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Prosight Management's 13F filing for Q2 2026, filed 14 Aug 2026.